Clinically validated, convenient and easy to useView our products
Would you like to learn more about our products? Request any information you wish to receive here.
Groningen, the Netherlands – January 7, 2016 Diagnoptics announces that it has been granted a Japan and EU patent for a method for skin colour independe......» read more
The AGE Reader and Diab-spot have received approval in a number of countries. Please check with the distributor in your country or Diagnoptics what the regulatory approval status is in your country. US Caution: Federal law restricts the AGE Reader and Diab-spot system to investigational use only. Commercial distribution has not been granted by the US FDA. Please see the AGE Reader and Diab-spot user manuals for descriptions of all relevant warnings, cautions, contraindications and safety information.